CJC-1295 (No DAC) + Ipamorelin (5 mg / 5 mg)

CJC-1295 (No DAC) + Ipamorelin is a research peptide blend combining a growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue receptor (GHSR) agonist. In laboratory research, this combination is widely studied for its interactions with the somatotropic axis, pituitary signaling pathways, endocrine regulation, and peptide receptor pharmacology. The complementary mechanisms of both peptides continue to make this blend an important research tool across endocrinology, hormone signaling, and metabolic biology studies.

Supplied as a lyophilized powder and sealed against light and moisture — shelf-stable before reconstitution, with no cold chain required until mixed. Every lot is independently assayed for identity and purity, with its Certificate of Analysis published before the compound is made available. Strictly intended for in-vitro laboratory research.

For In Vitro Research Use Only – Not for Human or Veterinary Application

Specifications

• Quantity: 10 mg Total

• Composition: CJC-1295 (No DAC) (5 mg) + Ipamorelin (5 mg)

• Form: Lyophilized Powder

• Compound: CJC-1295 (No DAC) + Ipamorelin Peptide Blend

• Purity: >99% (HPLC validated where applicable)

Intended Use

This compound is intended exclusively for in vitro laboratory research conducted by qualified professionals. It is not approved for human or veterinary use and must not be used in food, pharmaceuticals, cosmetics, or diagnostic applications.

Disclaimer

This product has not been evaluated by the U.S. Food and Drug Administration (FDA). It is not intended to diagnose, treat, cure, or prevent any disease. All research must be conducted in accordance with applicable laws, regulations, and accepted laboratory practices.